Literature DB >> 24560933

A single-nucleotide polymorphism in tumor necrosis factor-α (-308 G/A) as a biomarker in chronic pancreatitis.

K Sri Manjari1, A Jyothy1, P Shravan Kumar2, B Prabhakar3, M Uma Devi2, M Ramanna2, Pratibha Nallari4, A Venkateshwari5.   

Abstract

OBJECTIVE: Chronic pancreatitis is a gradual, long-term inflammation of the pancreas that results in alteration of its normal structure and function. The study aims to investigate the role of -308 (G/A) polymorphism of TNF-α gene in chronic pancreatitis.
MATERIAL AND METHODS: A total of 200 subjects were included in this case-control study. A total of 100 in patients admitted in the Gastroenterology Unit of Gandhi Hospital and Osmania General Hospital, Hyderabad were included in the present study. An equal number of healthy control subjects were randomly selected for the study. The genotyping of TNF-α gene was carried out by tetra-primer ARMS PCR followed by gel electrophoresis. The TNF-α levels were assayed by enzyme-linked immunosorbent assay.
RESULTS: A significant variation with respect to the genotypic and allelic distribution in the disease group when compared to control subjects [OR=2.001 (1.33-3.005), p<0.0001**] was observed. Subjects homozygous for the A allele had higher TNF-α levels compared to G allele.
CONCLUSION: The present study revealed a significant association of the TNF-α gene promoter polymorphism with chronic pancreatitis. Thus, TNF-α genotype can be considered as one of the biological markers in the etiology of chronic pancreatitis.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Genotypes; Inflammation; Pancreatic fibrosis; Pancreatic stellate cells

Mesh:

Substances:

Year:  2014        PMID: 24560933     DOI: 10.1016/j.gene.2014.02.014

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  6 in total

1.  Higher prevalence of the TNF-α G-308A heterozygous genotype in a South Indian population.

Authors:  Aditya K Panda; Harishankar Mahto
Journal:  Int J Clin Oncol       Date:  2017-03-22       Impact factor: 3.402

2.  TNFα G308A polymorphism is associated with resilience to sleep deprivation-induced psychomotor vigilance performance impairment in healthy young adults.

Authors:  Brieann C Satterfield; Jonathan P Wisor; Stephanie A Field; Michelle A Schmidt; Hans P A Van Dongen
Journal:  Brain Behav Immun       Date:  2014-12-24       Impact factor: 7.217

3.  Association of tumor necrosis factor-α -308 G/A gene polymorphism with coronary artery diseases: An evidence-based study.

Authors:  Elaheh Kazemi; Khadijeh Jamialahmadi; Amir Avan; Seyed Reza Mirhafez; Javad Mohiti; Maryam Pirhoushiaran; Nedasadat Hosseini; Akram Mohammadi; Gordon A Ferns; Alireza Pasdar; Majid Ghayour-Mobarhan
Journal:  J Clin Lab Anal       Date:  2017-02-23       Impact factor: 2.352

4.  Biomarkers of Chronic Pancreatitis: A systematic literature review.

Authors:  Zobeida Cruz-Monserrate; Kristyn Gumpper; Valentina Pita; Phil A Hart; Christopher Forsmark; David C Whitcomb; Dhiraj Yadav; Richard T Waldron; Stephen Pandol; Hanno Steen; Vincent Anani; Natasha Kanwar; Santhi Swaroop Vege; Savi Appana; Liang Li; Jose Serrano; Jo Ann S Rinaudo; Mark Topazian; Darwin L Conwell
Journal:  Pancreatology       Date:  2021-01-22       Impact factor: 3.996

5.  Characterisation of the fibroinflammatory process involved in progression from acute to chronic pancreatitis: study protocol for a multicentre, prospective cohort study.

Authors:  Srdan Novovic; Anders Borch; Mikkel Werge; David Karran; Lise Gluud; Palle Nordblad Schmidt; Erik Feldager Hansen; Camilla Nøjgaard; Annette Bøjer Jensen; Frank Krieger Jensen; Jens Brøndum Frøkjær; Mark Berner Hansen; Lars Nannestad Jørgensen; Asbjørn Mohr Drewes; Søren Schou Olesen
Journal:  BMJ Open       Date:  2019-08-21       Impact factor: 2.692

6.  The Risk of Chronic Pancreatitis in Patients with Psoriasis: A Population-Based Cohort Study.

Authors:  Hsien-Yi Chiu; Chi-Feng Hsieh; Yi-Ting Chiang; Weng-Foung Huang; Tsen-Fang Tsai
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.